Companies Dominating the Polyclonal Antibodies Landscape
- Abcam plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- GenScript Biotech Corporation
- BioLegend, Inc.
- Cell Signaling Technology, Inc.
- Rockland Immunochemicals Inc.
- Agilent Technologies, Inc.
- Fitzgerald Industries International
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Polyclonal Antibodies Market in 2025 is assessed at USD 1.73 billion.
The global market size was worth over USD 1.66 billion in 2024 and is poised to grow at a CAGR of around 5.4%, reaching USD 3.29 billion revenue by 2037.
Asia Pacific is likely to collect USD 1.55 billion by 2037, driven by extensive use of polyclonal antibodies in IHC.
The major players in the market include Abcam plc, Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories, Inc., GenScript Biotech Corporation, BioLegend, Inc., Cell Signaling Technology, Inc., Rockland Immunochemicals Inc., Agilent Technologies, Inc., Fitzgerald Industries International.
